Literature DB >> 17049426

Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats.

Fanzhu Li1, Jian Feng, Qiaoyuan Cheng, Wenjing Zhu, Yuji Jin.   

Abstract

In order to determine the contribution of intranasal (i.n.) administration to the uptake of large molecular weight (MW) substances into central nervous system (CNS), concentration in brain of the centrally acting polypeptide cobrotoxin (NT-I) versus time profiles were studied using dual-probe microdialysis in awake free-moving rats. NT-I, radiolabeled with sodium (125)I-Iodide ((125)I-NT-I), was administered at the dose of 105 microg/kg intravenously and intranasally in the same set of rat (n=15). The (125)I-NT-Inasal preparations were formulated with borneol/menthol eutectic mixture (+BMEM) as an absorption enhancer and without (-BMEM). After application, the dialysates sampled simultaneously from olfactory bulb and cerebellar nuclei were measured in a gamma-counter for radioactivity. The real concentrations of NT-I were recalculated by in vivo recoveries of microdialysis probes. The results showed that the area under the curve (AUC) value in cerebellar nuclei (2283.51+/-34.54 min ng/ml) following i.n. administration (+BMEM) was significantly larger than those (AUC(olfactory)=1141.92+/-26.42 min ng/ml; AUC(cerebellar)=1364.62+/-19.35 min ng/ml) after intravenous (i.v.) bolus, respectively. A prolonged time values to peak concentrations after i.n. application (+BMEM) were observed compared with those following i.v. administration. Also, following i.n. application (+BMEM) the measured time value to peak concentration in cerebellar nuclei (85 min) was statistically longer than that in olfactory bulb (75 min), which could be plausibly an indication for NT-I delivery into brain via nose-brain pathway in the presence of absorption enhancer. i.n. administration (-BMEM) had little or no ability of NT-I delivering into brain. In conclusion, i.n. administration (+BMEM) significantly enhanced brain transport of NT-I with uneven distribution in discrete regions of brain compared with i.v. administration. Additionally, multi-probe microdialysis technique should be considerably valuable in brain delivery studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049426     DOI: 10.1016/j.ijpharm.2006.08.011

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Comparative pharmacokinetics of borneol in cerebral ischemia-reperfusion and sham-operated rats.

Authors:  Pan Xu; Ying Li; Shou-ying Du; Yang Lu; Jie Bai; Qing-li Guo
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

2.  Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration.

Authors:  Yang Lu; Shou-ying Du; Xiao-lan Chen; Qing Wu; Xiao Song; Bing Xu; Yong-song Zhai
Journal:  J Zhejiang Univ Sci B       Date:  2011-02       Impact factor: 3.066

3.  Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion.

Authors:  Qi Shen; Xi Li; Wenji Li; Xinyi Zhao
Journal:  AAPS PharmSciTech       Date:  2011-08-13       Impact factor: 3.246

4.  Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption.

Authors:  Noha D Fayed; Mona F Arafa; Ebtesam A Essa; Gamal M El Maghraby
Journal:  J Drug Deliv Sci Technol       Date:  2022-07-11       Impact factor: 5.062

5.  Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria.

Authors:  Ya Tian; Zhongyuan Zheng; Xi Wang; Shuzhi Liu; Liwei Gu; Jing Mu; Xiaojun Zheng; Yujie Li; Shuo Shen
Journal:  J Nanobiotechnology       Date:  2022-07-06       Impact factor: 9.429

6.  Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations.

Authors:  Jing-yi Zhao; Yang Lu; Shou-ying Du; Xiao Song; Jie Bai; Yue Wang
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

Review 7.  Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability.

Authors:  Hyeongmin Kim; Jong Hyuk Lee; Jee Eun Kim; Young Su Kim; Choong Ho Ryu; Hong Joo Lee; Hye Min Kim; Hyojin Jeon; Hyo-Joong Won; Ji-Yun Lee; Jaehwi Lee
Journal:  J Ginseng Res       Date:  2018-01-09       Impact factor: 6.060

Review 8.  Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System.

Authors:  Jinxiu Li; Qian Xie; Rong Ma; Yong Li; Jianmei Yuan; Mihong Ren; Hongyan Li; Jiajun Wang; Danni Lu; Zhuo Xu; Jian Wang
Journal:  Front Med (Lausanne)       Date:  2021-11-25

9.  Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice.

Authors:  Yang Lu; Shouying Du; Jie Bai; Pengyue Li; Ran Wen; Xuejiao Zhao
Journal:  Int J Mol Sci       Date:  2012-11-01       Impact factor: 5.923

10.  Synergistic apoptosis-inducing effects on A375 human melanoma cells of natural borneol and curcumin.

Authors:  Jianping Chen; Lin Li; Jianyu Su; Bing Li; Tianfeng Chen; Yum-Shing Wong
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.